CONMED Corporation (NYSE: CNMD) today announced that it will report its financial results for the fourth quarter of 2022 after market close on Thursday, February 2, 2023. Following the announcement, the Company’s management will host a conference call at 4:30 pm ET on the same day to discuss the results. Join us for an exciting update on how CONMED Corporation is faring in the current quarter and what the future holds.
About CONMED Corporation
CONMED is a leading medical technology company that offers innovative surgical devices and equipment designed to make minimally invasive procedures more efficient and effective. Surgeons and physicians in a variety of specialties, such as orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology, rely on CONMED’s products to provide the best possible care to their patients.
Forward-Looking Statements
The Company is aware of the risks posed to its business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, and disruption to potential supply chain reliability. As such, the Company is prepared to handle any and all forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The Company’s performance on a going-forward basis is subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and the risks discussed in the Company’s Annual Report on Form 10-K for the full year ended December 31, 2021, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and listed in the Current Report filed on Form 8-K on November 15, 2022. Management is confident that its expectations, beliefs, and projections as expressed in the forward-looking statements will actually occur or prove to be correct.